Author:
Johnson Michael D.,Zuo Hong,Lee Kyung-Hoon,Trebley Joseph P.,Rae James Michael,Weatherman Ross V.,Desta Zeruesanay,Flockhart David A.,Skaar Todd C.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. American Cancer Society: Cancer Facts and Figures, 2002
2. Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med 339: 1609–1618, 1998
3. Furr BJ, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127–205, 1984
4. Stearns V, Johnson MD, Rae JM et al.: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst 95: 1758–1764, 2003
5. Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brosen K: Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Eur J Clin Pharmacol 51: 73–78, 1996
Cited by
391 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献